Axonics (Nasdaq:AXNX) announced today that a jury unanimously ruled in its favor in a patent spat with (NYSE: MDT).
DexCom's revised FY24 sales guidance in the Q2 earnings call led to a $18bn valuation reset. Read why I think DXCM stock is a ...
Medtronic PLC closed $2.15 below its 52-week high ($91.49), which the company reached on September 4th.
Medtronic's Financials For fiscal year (FY) 2023, Medtronic reported net sales of $31.2 billion (a 1.4% decrease from 2022) and a net income of $3.8 billion (a 25% year-over-year decrease).
In terms of guidance, Medtronic now expects 2025 revenue growth between 4.5% and 5%, a lift on the low end of the range from 4%. Similarly, the company sees full-year EPS in a range of $5.42 to $5 ...
Medtronic reiterated and affirmed its previously issued financial guidance for the first quarter of the 2025 fiscal year that ...
Shares of Medtronic PLC climbed toward a three-month high in early Tuesday trading, after the medical-technology company topped fiscal first-quarter earnings expectations, amid strength in its ...
While the stock has risen 4.2% in the past week but long term shareholders are still in the red, let's see what the fundamentals can tell us. View our latest analysis for Medtronic While the ...
To educate people on importance of being ethically conscious, aware, choosing the right path in case of conflict of interest and speak-up without fear when they see anything unethical. To make it ...
That said, Medtronic's operational execution is improving. Revenue increased around 3.6% in fiscal year 2024, although EPS fell about 1.5%. However, the company forecasts a 4% to 5% revenue ...
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the ...
By Maria Cramer and Hurubie Meko “We’ve got to take back 42nd Street,” Curtis Sliwa, the founder of the anti-crime group, said on “Hannity” as the Guardian Angels pushed a man to the ground.